Article thumbnail

Defensin-related peptide 1 (Defr1) is allelic to Defb8 and chemoattracts immature DC and CD4+ T cells independently of CCR6

By Karen Taylor, Mark Rolfe, Natalie Reynolds, Fiona Kilanowski, Uday Pathania, Dave Clarke, De Yang, Joost Oppenheim, Kay Samuel, Sarah Howie, Perdita Barran, Derek Macmillan, Dominic Campopiano and Julia Dorin


β-Defensins comprise a family of cationic, antimicrobial and chemoattractant peptides. The six cysteine canonical motif is retained throughout evolution and the disulphide connectivities stabilise the conserved monomer structure. A murine β-defensin gene (Defr1) present in the main defensin cluster of C57B1/6 mice, encodes a peptide with only five of the canonical six cysteine residues. In other inbred strains of mice, the allele encodes Defb8, which has the six cysteine motif. We show here that in common with six cysteine β-defensins, defensin-related peptide 1 (Defr1) displays chemoattractant activity for CD4+ T cells and immature DC (iDC), but not mature DC cells or neutrophils. Murine Defb2 replicates this pattern of attraction. Defb8 is also able to attract iDC but not mature DC. Synthetic analogues of Defr1 with the six cysteines restored (Defr1 Y5C) or with only a single cysteine (Defr1-1cV) chemoattract CD4+ T cells with reduced activity, but do not chemoattract DC. β-Defensins have previously been shown to attract iDC through CC receptor 6 (CCR6) but neither Defr1 or its related peptides nor Defb8, chemoattract cells overexpressing CCR6. Thus, we demonstrate that the canonical six cysteines of β-defensins are not required for the chemoattractant activity of Defr1 and that neither Defr1 nor the six cysteine polymorphic variant allele Defb8, act through CCR6

Topics: Innate immunity
Publisher: WILEY-VCH Verlag
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2007). A beta-defensin mutation causes black coat color in domestic dogs. Science
  2. (2007). A haplotype map for the laboratory mouse.
  3. (2007). A sequence-based variation map of 8.27 million SNPs in inbred mouse strains. Nature
  4. (2009). Analysis and separation of residues important for
  5. and IL-13 negatively regulate TNFalpha- and IFN-gamma-induced beta-defensin expression through STAT-
  6. (1999). Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science
  7. (2007). betaDefensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR6 is not involved.
  8. (2007). Covalent dimer species of betadefensin Defr1 display potent antimicrobial activity against multidrugresistant bacterial pathogens. Antimicrob. Agents Chemother.
  9. (2005). Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract.
  10. Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3.
  11. (1992). Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.
  12. (2004). Human betadefensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology
  13. (2007). Identification and biological characterization of mouse beta-defensin 14 – the orthologue of human beta defensin 3.
  14. (2002). Identification and characterization of a novel murine beta-defensinrelated gene.
  15. Inside the gearbox of the dendritic cell.
  16. (2001). Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic.
  17. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol.
  18. (2001). Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens.
  19. (2001). Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37).
  20. (2001). Structure determination of human and murine beta-defensins reveals structural conservation in the absence of significant sequence similarity. Protein Sci.
  21. (2004). Structure-activity relationships in defensin dimers: a novel link between beta-defensin tertiary structure and antimicrobial activity.
  22. (2007). Studies of the biological properties of human beta-defensin 1.
  23. (2007). suppressor of cytokine signaling (SOCS)-1, and SOCS-3.
  24. (2005). The complexity of selection at the major primate beta-defensin locus.
  25. (2002). The structure of human MIP-3alpha/CCL20: Linking antimicrobial and CCR6 receptor binding activities with human betadefensins.
  26. (2002). Toll-like receptor 4-dependent activation of dendritic cells by beta- defensin 2. Science
  27. (2004). Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A.